Iotron Industries
Acquisition in 2020
Iotron Industries Canada, Inc. is a company based in Port Coquitlam, British Columbia, specializing in electron beam technology. Established in 1989, it provides essential services such as sterilization, bio-reduction, and materials modification to various sectors, including orthopedic and medical devices, plastics, agribusiness, and commercial defense. As a subsidiary of Sterigenics U.S., LLC since July 31, 2020, Iotron Industries aims to enhance product safety and performance through its advanced electron beam services.
Gibraltar Laboratories
Acquisition in 2018
Gibraltar Laboratories is a provider of sterilization, microbiology, virology, and analytical chemistry services for pharmaceutical, medical device, orthopedic, tissue bank, biopharmaceutical, biotech, nutraceutical, cosmetic, and related industries. The company offers compendial testing of raw materials and drug products, forced-degradation and stability studies, and development and validation of test methods for active drug substances and dosage forms, including dissolution method validation and validation testing for cleaning procedures and process validation. It delivers residual solvents testing, ion chromatography, particulates, hemoglobin, ETO residuals, and other chemistry studies, along with protocol development and validation for microbiological and chemical validations, method transfer, and qualification of APIs and raw materials. In addition, Gibraltar Laboratories provides sterilization protocol development, bioburden testing, and environmental monitoring services in pharmaceutical plants, covering water, nitrogen, compressed air, and other gases for airborne contaminants. The firm also evaluates vaccine/host systems for microbiological considerations and performs environmental monitoring to ensure product safety and quality.
Toxikon Europe
Acquisition in 2017
Toxikon Europe N.V., based in Leuven, Belgium, specializes in contract research services for the biotech, pharmaceutical, and medical device sectors. The company offers a comprehensive range of integrated analytical, material characterization, and microbiological services, including extractable and leachable testing. These services support drug and device development by ensuring product safety and regulatory compliance, while upholding stringent laboratory quality control standards. By providing these essential services, Toxikon Europe enables its clients to enhance the efficiency and speed of their product development processes, ultimately facilitating a quicker market entry for their innovations. As of October 31, 2017, Toxikon Europe operates as a subsidiary of Sterigenics International, Inc.
Nelson Laboratories
Acquisition in 2016
Nelson Laboratories is a prominent provider of microbiological testing services for medical technology companies. It offers precise test results and expert consulting to ensure the safety and efficacy of products, thereby minimizing client risk.
Companhia Brasileira de Esterilização
Acquisition in 2015
Companhia Brasileira de Esterilização is a prominent provider of gamma sterilization services in Brazil and Latin America. The company specializes in sterilization and microbial load reduction, utilizing advanced gamma technologies to ensure the safety and efficacy of medical products. It offers a range of services, including sterilization processes and the application of medical isotopes, facilitated through the use of E-BEAM accelerator technology. By focusing on these critical services, Companhia Brasileira de Esterilização plays a vital role in enhancing public health by ensuring that medical devices and products meet stringent safety standards.
Gammarad
Acquisition in 2014
Gammarad provides gamma irradiation sterilisation services for the biomedical, pharmaceutical, food packaging, and cosmetics industries.
Nordion
Acquisition in 2014
Nordion is a global health science company specializing in products that aid in the prevention, diagnosis, and treatment of disease. It is recognized as a leading provider of sterilization technologies and medical isotopes, which are essential in the healthcare sector. Nordion's offerings include pharmaceutical research services, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. These products are utilized by a diverse range of clients, including pharmaceutical and biotechnology companies, medical device manufacturers, hospitals, clinics, and research laboratories, impacting the lives of millions across more than 40 countries.